{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:03:50Z","timestamp":1784552630113,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cmi.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:27:32Z","timestamp":1775842052000},"page":"1211-1215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rethinking informed consent in phage therapy: why location and approach matter"],"prefix":"10.1016","volume":"32","author":[{"given":"Ran","family":"Nir-Paz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Pirnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Drulis-Kawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika Y.","family":"Classen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia I.","family":"Scobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Katvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Hafkemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna","family":"McCallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina A.","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.04.007_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2024.21972","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human participants","volume":"333","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2026.04.007_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cmi.2025.07.032","article-title":"The importance of patient information and informed consent for unlicensed phage therapy","volume":"32","author":"Jones","year":"2026","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.04.007_bib3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/ph19010162","article-title":"Phage therapy at the crossroads between clinical promise and regulatory challenge","volume":"19","author":"Gallina","year":"2026","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.cmi.2026.04.007_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","article-title":"Phage therapy: from biological mechanisms to future directions","volume":"186","author":"Strathdee","year":"2023","journal-title":"Cell"},{"issue":"Suppl 5","key":"10.1016\/j.cmi.2026.04.007_bib5","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1093\/cid\/ciad481","article-title":"Magistral phage preparations: is this the model for everyone?","volume":"77","author":"Pirnay","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.04.007_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/v10020064","article-title":"The magistral phage","volume":"10","author":"Pirnay","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.cmi.2026.04.007_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coviro.2021.11.005","article-title":"European regulatory aspects of phage therapy: magistral phage preparations","volume":"52","author":"Verbeken","year":"2022","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.cmi.2026.04.007_bib8","series-title":"Bacteriophage Therapy for Difficult-to-treat Infections: the Implementation of a Multidisciplinary Phage Task Force (PHAGEFORCE)","year":"2024"},{"key":"10.1016\/j.cmi.2026.04.007_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065401","article-title":"Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial","volume":"12","author":"Khatami","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2026.04.007_bib10","series-title":"Phagistry\u2014Registry for patients receiving phage therapy","year":"2026"},{"key":"10.1016\/j.cmi.2026.04.007_bib11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3390\/v14061170","article-title":"A thorough synthesis of phage therapy unit activity in Poland\u2013its history, milestones and international recognition","volume":"14","author":"\u017baczek","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.cmi.2026.04.007_bib12","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/jac\/dkae325","article-title":"Phage susceptibility testing methods or \u2018phagograms\u2019: where do we stand and where should we go?","volume":"79","author":"Kolenda","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.04.007_bib13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cmi.2023.02.006","article-title":"Clinical phage microbiology: a narrative summary","volume":"29","author":"Suh","year":"2023","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26001916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26001916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:22:55Z","timestamp":1784550175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26001916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1198743X26001916"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.04.007","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking informed consent in phage therapy: why location and approach matter","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}